June 2022

Otsuka Pharmaceutical India Private Limited is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, for Infusion Business in India and Emerging Markets. We primarily manufacture & market products across multiple markets and therapeutic segments. Being a leader in intravenous nutrition products, we are committed to being the best partner of patients and healthcare professionals in the field of clinical nutrition.

At Medtronic, we push the limits of what technology, therapies and services can do to help alleviate pain, restore health and extend life. We challenge ourselves and each other to make tomorrow better than yesterday. It is what makes this an exciting and rewarding place to be. We want to accelerate and advance our ability to create meaningful innovations - but we will only succeed with the right people on our team. Let’s work together to address universal healthcare needs and improve patients’ lives. Help us shape the future.

Jodas is a Global, specialty, innovation driven, emerging, generic bio- pharmaceutical company, that is asserting itself among the worlds foremost pharmaceutical companies. JEPL is having EU GMP certification of Oncology (orals), Contrast Media (SVP and LVP) and facility for Cephalosporins currently delivering the products like Anti-Cancer and Antibiotics, Contrast media.

Olema Pharmaceuticals, Inc. and Aurigene Discovery Technologies Limited announced an exclusive global license agreement to research, develop and commercialize novel small molecule inhibitors of an undisclosed oncology target.

Alembic Pharmaceuticals Limited announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Sprycel Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, of Bristol Myers Squibb Company (BMS).

Kabirdham district is one of the 28 administrative districts of Chhattisgarh state in central India. The district was earlier known as Kawardha district. The district is located between 21.32' to 22.28' north latitude and 80.48' to 81.48' east longitude.

Post : Pharmacist

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

The Institute of Nuclear Medicine and Allied Sciences (INMAS) is a mandated multidisciplinary laboratory of DRDO engaged in R&D activities in the field of Radiation,Imaging Sciences and CBRN technologies. INMAS is one of the very few Institutions that can boast of having an enviable contingent of highly skilled Scientists, clinical researchers and biomedical professionals working towards common goals and objectives.

Indian Institute of Science Education and Research Pune is a premier autonomous Institution established by the Ministry of Education, Government of India, for the promotion of high-quality science education and research in the country.

Institute invites applications from Indian nationals having excellent academic record and relevant work experience for the following position purely on temporary and contractual basis under Animal house facility: